63 related articles for article (PubMed ID: 2947330)
21. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
22. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
Toki N; Takasugi S; Sumi H; Yamura T
Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
[TBL] [Abstract][Full Text] [Related]
23. A new fluorogenic substrate for plasmin.
Pierzchala PA; Dorn CP; Zimmerman M
Biochem J; 1979 Dec; 183(3):555-9. PubMed ID: 161507
[TBL] [Abstract][Full Text] [Related]
24. In vitro degradation of radiolabelled, intact basement membrane mediated by cellular plasminogen activator.
Sheela S; Barrett JC
Carcinogenesis; 1982; 3(4):363-9. PubMed ID: 7201358
[No Abstract] [Full Text] [Related]
25. Protamine, a substrate for thrombolytic agents and enzymes of similar specificity.
Ong EB; Johnson AJ
Anal Biochem; 1976 Oct; 75(2):568-82. PubMed ID: 136215
[No Abstract] [Full Text] [Related]
26. Degradation of muscle basement membrane zone by locally generated plasmin.
Hantaï D; Festoff BW
Exp Neurol; 1987 Jan; 95(1):44-55. PubMed ID: 2947809
[TBL] [Abstract][Full Text] [Related]
27. Binding of human plasminogen to basement-membrane (type IV) collagen.
Stack MS; Moser TL; Pizzo SV
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):103-8. PubMed ID: 1599390
[TBL] [Abstract][Full Text] [Related]
28. Nature of the glycoprotein components of basement membranes.
Spiro RG
Ann N Y Acad Sci; 1978 Jun; 312():106-21. PubMed ID: 386880
[No Abstract] [Full Text] [Related]
29. Organ cultures of the embryonic rat parietal yolk sac. I. Morphologic and autoradiographic studies of the deposition of the collagen and noncollagen glycoprotein components of basement membrane.
Minor RR; Hoch PS; Koszalka TR; Brent RL; Kefalides NA
Dev Biol; 1976 Feb; 48(2):344-64. PubMed ID: 1254086
[No Abstract] [Full Text] [Related]
30. Activation of trypsinogen by plasmin.
Goldblat MV; Kline DL; Milstone JH
Proc Soc Exp Biol Med; 1967 Jul; 125(3):763-6. PubMed ID: 15938260
[No Abstract] [Full Text] [Related]
31. Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin.
Liotta LA; Goldfarb RH; Terranova VP
Thromb Res; 1981 Mar; 21(6):663-73. PubMed ID: 6455777
[No Abstract] [Full Text] [Related]
32. Organ cultures of the embryonic rat parietal yolk sac. II. Synthesis, accumulation, and turnover of collagen and noncollagen basement membrane glycoproteins.
Minor RR; Strause EL; Koszalka TR; Brent RL; Kefalides NA
Dev Biol; 1976 Feb; 48(2):365-76. PubMed ID: 1254087
[No Abstract] [Full Text] [Related]
33. Extraordinary bladder clots.
Keiller DL
J Urol; 1977 Jan; 117(1):43-5. PubMed ID: 137329
[TBL] [Abstract][Full Text] [Related]
34. Biochemistry and metabolism of basement membranes.
Kefalides NA; Alper R; Clark CC
Int Rev Cytol; 1979; 61():167-228. PubMed ID: 389868
[No Abstract] [Full Text] [Related]
35. Mechanisms of invasion by head and neck cancers.
Boyd DD; Nicolson GL
Cancer Treat Res; 1995; 74():117-30. PubMed ID: 7779611
[No Abstract] [Full Text] [Related]
36. Stromal involvement in malignant growth.
van den Hooff A
Adv Cancer Res; 1988; 50():159-96. PubMed ID: 3287842
[No Abstract] [Full Text] [Related]
37. Degradation of basement membrane collagen by proteases from some anaerobic oral micro-organisms.
Uitto VJ; Haapasalo M; Laakso T; Salo T
Oral Microbiol Immunol; 1988 Sep; 3(3):97-102. PubMed ID: 3077815
[No Abstract] [Full Text] [Related]
38. Selective inactivation of the plasminogen contaminant in thrombin.
MARKUS G; AMBRUS CM
Nature; 1960 Nov; 188():582-3. PubMed ID: 13766973
[No Abstract] [Full Text] [Related]
39. Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.
Yamamoto M; Sawaya R; Mohanam S; Rao VH; Bruner JM; Nicolson GL; Ohshima K; Rao JS
J Neurooncol; 1994; 22(2):139-51. PubMed ID: 7745466
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I
Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
